Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3. (Q39916513)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3. |
scientific article |
Statements
Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3 (English)
Dana D Hu-Lowe
Helen Y Zou
Maren L Grazzini
Max E Hallin
Grant R Wickman
Karin Amundson
Jeffrey H Chen
David A Rewolinski
Shinji Yamazaki
Ellen Y Wu
Michele A McTigue
Robert S Kania
Patrick O'Connor
David R Shalinsky